William Blair
http://www.williamblair.comWilliam Blair & Company, L.L.C. is a Chicago-based investment firm offering investment banking, asset management, equity research, institutional and private brokerage, and private capital to individual, institutional, and issuing clients. Since 1935, it has been committed to helping clients achieve their financial objectives.
-
Catalent, Inc. to Present at June Investor Conferences
-
Catalent, Inc. to Present at the Jefferies Healthcare Conference and the William Blair Growth Stock Conference
-
Catalent, Inc. to Present at June 2020 Virtual Investor Conferences
-
Catalent (CTLT) Reports Acquisition of Bristol-Myers Squibb (BMY) Manufacturing Facility in Anagni, Italy
-
Catalent to Purchase Bristol-Myers Squibb Manufacturing Facility in Anagni, Italy
-
Catalent to Purchase Bristol-Myers Squibb Manufacturing Facility in Anagni, Italy
-
Catalent to acquire gene therapy leader Paragon Bioservices, Inc. for $1.2 billion
-
Catalent (CTLT) to Acquire Paragon Bioservices for $1.2 Billion
-
Catalent to Acquire Gene Therapy Leader Paragon Bioservices, Inc. for $1.2 Billion
-
Catalent, Inc. to Present at Four Upcoming Investor Conferences
-
Catalent, Inc. to Present at William Blair & Company’s 37th Annual Growth Stock Conference
-
William Blair Upgrades Catalent (CTLT) to Outperform
-
William Blair Downgrades Catalent (CTLT) to Market Perform
-
Catalent (CTLT) Prices 14M Common Secondary Offering at $29/Share
-
Catalent, Inc. Announces Pricing of Secondary Public Offering of Common Stock
-
Catalent (CTLT) Announces 20M Common Stock Secondary Offering
-
Catalent, Inc. Announces Launch of Secondary Public Offering of Common Stock
-
Catalent, Inc. to Present at Three Investor Conferences in June
-
Catalent, Inc. Closes Secondary Public Offering of Common Stock
-
Catalent (CTLT) 23.7M Secondary Offering Prices at $29.50/Share
-
Catalent (CTLT) Announces 20M Common Secondary Offering
-
William Blair Starts Catalent (CTLT) at Outperform
-
Catalent (CTLT) IPO Opens Slightly Lower

